SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $78,520 | -61.7% | 130,911 | -17.1% | 0.00% | -100.0% |
Q2 2023 | $205,205 | +18.0% | 157,850 | +59.7% | 0.00% | 0.0% |
Q1 2023 | $173,927 | -61.7% | 98,822 | -31.7% | 0.00% | -50.0% |
Q4 2022 | $454,484 | +131.9% | 144,740 | +262.4% | 0.00% | +100.0% |
Q3 2022 | $196,000 | -90.7% | 39,939 | -70.5% | 0.00% | -88.9% |
Q4 2020 | $2,109,000 | +44.5% | 135,166 | -12.5% | 0.01% | +50.0% |
Q3 2020 | $1,460,000 | +24.3% | 154,449 | +17.8% | 0.01% | 0.0% |
Q2 2020 | $1,175,000 | +230.1% | 131,139 | +134.4% | 0.01% | +200.0% |
Q1 2020 | $356,000 | +9.2% | 55,949 | +43.6% | 0.00% | +100.0% |
Q4 2019 | $326,000 | -7.4% | 38,949 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $352,000 | -70.0% | 38,949 | -64.2% | 0.00% | -75.0% |
Q2 2019 | $1,172,000 | +19.5% | 108,798 | +5.8% | 0.00% | 0.0% |
Q1 2019 | $981,000 | +23.4% | 102,798 | +48.4% | 0.00% | 0.0% |
Q4 2018 | $795,000 | -67.3% | 69,278 | -51.6% | 0.00% | -55.6% |
Q3 2018 | $2,428,000 | +19.5% | 143,252 | +0.1% | 0.01% | +12.5% |
Q2 2018 | $2,032,000 | +86.9% | 143,092 | +150.2% | 0.01% | +60.0% |
Q1 2018 | $1,087,000 | – | 57,192 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
Leisure Capital Management | 43,008 | $131,000 | 0.12% |
Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |